York Opioid Collaborative
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2018 | 101,050 | 79,641 | 21,409 | 13.5 | 0% |
| 2019 | 177,586 | 96,590 | 80,996 | 21.2 | 14% |
| 2020 | 152,952 | 125,304 | 27,648 | 19.0 | 48% |
| 2021 | 272,853 | 131,806 | 141,047 | 30.9 | 49% |
| 2022 | 132,134 | 189,809 | −57,675 | 17.8 | 35% |
| 2023 | 226,136 | 184,283 | 41,853 | 21.0 | 38% |
| 2024 | 567,683 | 292,503 | 275,180 | 24.5 | 39% |
In its most recent public year (2024), this organization brought in $275,180 more than it spent. Its reserves stood at about 24.5 months of spending, up from 13.5 in 2018. Staff pay was 39% of spending. $273,677 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2024. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
York Opioid Collaborative's IRS filings as a feed — one entry per filing year, through 2024. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works